Abt199
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
713 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | 172 | 245 | 50 | 3 | 64 | 455 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 143 | 169 | 28 | 2 | 48 | 330 |
| Myeloid leukemia | D007951 | — | C92 | 121 | 146 | 23 | 2 | 43 | 287 |
| Lymphoid leukemia | D007945 | — | C91 | 50 | 91 | 25 | 1 | 20 | 159 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 33 | 66 | 24 | 2 | 17 | 129 |
| Heart failure | D006333 | EFO_0003144 | I50 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | 72 | 84 | 9 | — | 3 | 136 |
| Myelodysplastic syndromes | D009190 | — | D46 | 57 | 51 | 2 | — | 3 | 86 |
| Preleukemia | D011289 | — | — | 46 | 38 | 2 | — | 1 | 66 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 25 | 41 | 4 | — | 8 | 61 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 41 | 24 | 1 | — | 2 | 54 |
| Syndrome | D013577 | — | — | 35 | 34 | 1 | — | — | 52 |
| Neoplasms | D009369 | — | C80 | 28 | 22 | 4 | — | 4 | 47 |
| Recurrence | D012008 | — | — | 24 | 32 | 1 | — | 1 | 44 |
| Mantle-cell lymphoma | D020522 | — | C83.1 | 15 | 26 | 2 | — | 1 | 36 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 22 | 14 | 1 | — | 2 | 31 |
Show 10 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 21 | 23 | — | — | 1 | 32 |
| Myelomonocytic leukemia juvenile | D054429 | — | C93.3 | 21 | 22 | — | — | 1 | 31 |
| Hematologic neoplasms | D019337 | — | — | 20 | 14 | — | — | 3 | 26 |
| Follicular lymphoma | D008224 | — | C82 | 14 | 12 | — | — | 1 | 21 |
| Myeloproliferative disorders | D009196 | — | D47.1 | 9 | 9 | — | — | 1 | 16 |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 3 | 9 | — | — | 2 | 12 |
| B-cell lymphoma marginal zone | D018442 | — | C88.4 | 8 | 6 | — | — | — | 12 |
| Myelomonocytic leukemia acute | D015479 | — | C92.5 | 6 | 9 | — | — | — | 10 |
| Residual neoplasm | D018365 | — | — | — | 7 | — | — | 1 | 8 |
| Philadelphia chromosome | D010677 | — | — | 2 | 6 | — | — | 1 | 8 |
Show 48 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Carcinoma | D002277 | — | C80.0 | 4 | — | — | — | — | 4 |
| Prostatic neoplasms | D011471 | — | C61 | 3 | — | — | — | — | 3 |
| Castration-resistant prostatic neoplasms | D064129 | — | — | 2 | — | — | — | — | 2 |
| Hodgkin disease | D006689 | — | C81 | 1 | — | — | — | 1 | 2 |
| Blastic plasmacytoid dendritic cell neoplasm | D000099067 | — | C86.4 | 2 | — | — | — | — | 2 |
| Non-small-cell lung carcinoma | D002289 | — | — | 2 | — | — | — | — | 2 |
| Aggression | D000374 | EFO_0003015 | — | 2 | — | — | — | — | 2 |
| Gata2 deficiency | D000077428 | — | D46.22 | 2 | — | — | — | — | 2 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | — | — | — | — | 1 |
| Anemia | D000740 | EFO_0004272 | D64.9 | 1 | — | — | — | — | 1 |
Show 15 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Frailty | D000073496 | — | R53.1 | — | — | — | — | 1 | 1 |
| Plasma cell leukemia | D007952 | — | C90.1 | — | — | — | — | 1 | 1 |
| Congenital abnormalities | D000013 | EFO_0003915 | Q89.9 | — | — | — | — | 1 | 1 |
| Eye abnormalities | D005124 | — | Q15.9 | — | — | — | — | 1 | 1 |
| Chromosome aberrations | D002869 | Orphanet_68335 | — | — | — | — | — | 1 | 1 |
| Chromosome disorders | D025063 | EFO_0003831 | Q99.9 | — | — | — | — | 1 | 1 |
| Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | — | — | — | — | 1 | 1 |
| Sudden death cardiac | D016757 | EFO_0004278 | — | — | — | — | — | 1 | 1 |
| Death | D003643 | PATO_0001422 | — | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use